A detailed history of Jane Street Group, LLC transactions in Argenx Se stock. As of the latest transaction made, Jane Street Group, LLC holds 8,810 shares of ARGX stock, worth $5.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,810
Previous 19,306 54.37%
Holding current value
$5.5 Million
Previous $8.3 Million 42.45%
% of portfolio
0.0%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$434.22 - $551.9 $4.56 Million - $5.79 Million
-10,496 Reduced 54.37%
8,810 $4.78 Million
Q2 2024

Aug 14, 2024

SELL
$356.01 - $451.55 $18,868 - $23,932
-53 Reduced 0.27%
19,306 $8.3 Million
Q1 2024

May 15, 2024

SELL
$356.95 - $413.29 $2.33 Million - $2.7 Million
-6,535 Reduced 25.24%
19,359 $7.62 Million
Q4 2023

Feb 14, 2024

BUY
$338.91 - $506.01 $4.84 Million - $7.22 Million
14,268 Added 122.72%
25,894 $9.85 Million
Q3 2023

Nov 14, 2023

BUY
$369.35 - $548.43 $6,648 - $9,871
18 Added 0.16%
11,626 $5.72 Million
Q2 2023

Aug 14, 2023

BUY
$360.14 - $422.58 $3.51 Million - $4.11 Million
9,737 Added 520.42%
11,608 $4.52 Million
Q1 2023

May 15, 2023

SELL
$334.23 - $403.65 $1.64 Million - $1.99 Million
-4,921 Reduced 72.45%
1,871 $697,000
Q4 2022

Feb 14, 2023

SELL
$342.17 - $402.31 $11 Million - $12.9 Million
-32,176 Reduced 82.57%
6,792 $2.57 Million
Q3 2022

Nov 14, 2022

BUY
$343.2 - $395.75 $13.4 Million - $15.4 Million
38,968 New
38,968 $13.8 Million
Q4 2021

Feb 15, 2022

SELL
$272.01 - $353.03 $10.6 Million - $13.8 Million
-38,974 Reduced 73.43%
14,101 $4.94 Million
Q3 2021

Nov 16, 2021

BUY
$295.0 - $350.58 $10.6 Million - $12.6 Million
35,800 Added 207.24%
53,075 $16 Million
Q2 2021

Aug 16, 2021

SELL
$257.11 - $319.92 $11.4 Million - $14.2 Million
-44,296 Reduced 71.94%
17,275 $5.2 Million
Q4 2020

Feb 17, 2021

BUY
$248.13 - $308.36 $10.4 Million - $13 Million
42,018 Added 214.89%
61,571 $18.1 Million
Q3 2020

Nov 17, 2020

SELL
$215.51 - $272.51 $1.6 Million - $2.03 Million
-7,432 Reduced 27.54%
19,553 $5.13 Million
Q2 2020

Aug 17, 2020

BUY
$127.44 - $232.72 $2 Million - $3.66 Million
15,726 Added 139.67%
26,985 $6.08 Million
Q1 2020

May 15, 2020

SELL
$108.83 - $165.23 $13.3 Million - $20.1 Million
-121,845 Reduced 91.54%
11,259 $1.48 Million
Q4 2019

Feb 14, 2020

BUY
$106.59 - $164.21 $14.2 Million - $21.9 Million
133,104 New
133,104 $21.4 Million
Q1 2019

May 16, 2019

SELL
$98.85 - $134.59 $1.4 Million - $1.91 Million
-14,155 Closed
0 $0
Q4 2018

Feb 15, 2019

SELL
$63.81 - $109.82 $5.18 Million - $8.91 Million
-81,143 Reduced 85.15%
14,155 $1.36 Million
Q3 2018

Nov 14, 2018

BUY
$75.5 - $96.63 $6.61 Million - $8.47 Million
87,614 Added 1140.21%
95,298 $7.23 Million
Q2 2018

Aug 15, 2018

SELL
$74.84 - $100.16 $823 - $1,101
-11 Reduced 0.14%
7,684 $637,000
Q1 2018

May 15, 2018

BUY
$56.95 - $85.19 $438,230 - $655,537
7,695 New
7,695 $619,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.5B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.